NovaBay Pharmaceuticals Inc (NBY)
0.7276
+0.02
(+2.12%)
USD |
NYAM |
Nov 14, 16:00
0.7276
0.00 (0.00%)
After-Hours: 18:02
NovaBay Pharmaceuticals Free Cash Flow (Quarterly): -0.58M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.58M |
| March 31, 2024 | -1.574M |
| December 31, 2023 | -0.316M |
| September 30, 2023 | -0.926M |
| June 30, 2023 | -1.708M |
| March 31, 2023 | -1.20M |
| December 31, 2022 | -1.209M |
| September 30, 2022 | -1.769M |
| June 30, 2022 | -1.707M |
| March 31, 2022 | -2.081M |
| December 31, 2021 | -4.326M |
| September 30, 2021 | -1.485M |
| June 30, 2021 | -1.989M |
| March 31, 2021 | -1.444M |
| December 31, 2020 | -1.466M |
| September 30, 2020 | -1.375M |
| June 30, 2020 | -1.041M |
| March 31, 2020 | -0.865M |
| December 31, 2019 | -1.429M |
| September 30, 2019 | -1.50M |
| June 30, 2019 | -1.784M |
| March 31, 2019 | -3.235M |
| December 31, 2018 | -2.024M |
| September 30, 2018 | -1.626M |
| June 30, 2018 | -1.496M |
| Date | Value |
|---|---|
| March 31, 2018 | -0.466M |
| December 31, 2017 | -2.942M |
| September 30, 2017 | 0.208M |
| June 30, 2017 | -1.715M |
| March 31, 2017 | -2.065M |
| December 31, 2016 | -0.302M |
| September 30, 2016 | -3.889M |
| June 30, 2016 | -2.681M |
| March 31, 2016 | -4.949M |
| December 31, 2015 | -4.566M |
| September 30, 2015 | -4.162M |
| June 30, 2015 | -5.433M |
| March 31, 2015 | -4.521M |
| December 31, 2014 | -4.145M |
| September 30, 2014 | -2.788M |
| June 30, 2014 | -3.762M |
| March 31, 2014 | -4.428M |
| December 31, 2013 | -4.78M |
| September 30, 2013 | -2.411M |
| June 30, 2013 | -2.218M |
| March 31, 2013 | -3.701M |
| December 31, 2012 | -3.19M |
| September 30, 2012 | 0.208M |
| June 30, 2012 | -0.958M |
| March 31, 2012 | -2.736M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-4.326M
Minimum
Dec 2021
-0.316M
Maximum
Dec 2023
-1.500M
Average
-1.444M
Median
Mar 2021
Free Cash Flow (Quarterly) Benchmarks
| Palatin Technologies Inc | -6.477M |
| iBio Inc | -4.854M |
| Theriva Biologics Inc | -3.453M |
| Oragenics Inc | -1.544M |
| Nanoviricides Inc | -1.580M |